Cai Zhiqiang, Cao Ran, Zhang Kai, Xue Yuanchao, Zhang Chen, Zhou Yu, Zhou Jie, Sun Hui, Fu Xiang-Dong
From the State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China and.
Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093-0651.
J Biol Chem. 2015 Aug 7;290(32):19967-75. doi: 10.1074/jbc.M115.661504. Epub 2015 Jun 27.
MicroRNAs (miRs) are a class of small regulatory RNAs that have been implicated in diverse biological pathways, including cancer. miR-17/20a encoded by the c13orf25 locus is among the first miRs discovered to have oncogenic functions. The E2F family members have been established as the targets for these oncomiRs, which form a negative feedback loop to control cell cycle progression. However, this pathway does not seem to be sufficient to account for elevated expression of these oncomiRs in cancer cells to promote tumorigenesis. Here we report that miR-17/20a targets a p53 activating kinase DAPK3, leading to p53-dependent transcriptional de-repression of the oncomiRs. We demonstrate that DAPK3 plays a central role in preventing miR-17/20a depletion-induced genome instability and in miR-17/20a overexpression-triggered tumor formation. This newly identified tumorigenic pathway may thus contribute to miR-17/20a amplification and tumor growth in diverse human cancers.
微小RNA(miR)是一类小的调节性RNA,已被证明参与多种生物途径,包括癌症。由c13orf25基因座编码的miR-17/20a是最早被发现具有致癌功能的miR之一。E2F家族成员已被确定为这些致癌miR的靶标,它们形成一个负反馈环来控制细胞周期进程。然而,这一途径似乎不足以解释癌细胞中这些致癌miR的表达升高以促进肿瘤发生的现象。在此,我们报告miR-17/20a靶向一种p53激活激酶DAPK3,导致致癌miR的p53依赖性转录去抑制。我们证明DAPK3在防止miR-17/20a缺失诱导的基因组不稳定以及在miR-17/20a过表达引发的肿瘤形成中起核心作用。因此,这种新发现的致癌途径可能有助于miR-17/20a在多种人类癌症中的扩增和肿瘤生长。